• Home
  • Victims
    • Vaccine Victims Memorial
    • Gardasil & Silgard
      • G / S Australasia
        • G / S Australia
        • G / S New Zealand
      • G / S Europe
        • G / S Czech Republic
        • G / S Denmark
        • G / S France
        • G / S Germany
        • G / S Ireland
        • G / S Italy
        • G / S Norway
        • G / S Scotland
        • G / S Spain
        • G / S United Kingdom
      • G / S N. America
        • G / S Canada
        • G / S Mexico
        • G / S United States
      • G / S S. America
        • G / S Brazil
        • G/S Colombia
    • Cervarix
      • Cervarix Asia
        • Cervarix India
        • Cervarix Philippines
      • Cervarix Europe
        • Cervarix Czech
        • Cervarix Netherlands
        • Cervarix Scotland
        • Cervarix Slovakia
        • Cervarix Spain
        • Cervarix UK
      • Cervarix N. America
        • Cervarix Mexico
  • Resources
    • HPV Testing Resources
      • Pre-HPV Vaccination
      • Post-HPV Vaccination
    • Medical Professionals
    • Vaccine Injury Attorneys
    • Political Action Groups
    • Vaccine Groups
    • Vaccine Victims Hotline
  • SANE Vax Press Releases
  • Videos
    • Vaccine Safety Videos
    • Vaccine Victim Videos
    • Pharma Videos
  • About
    • About Us
    • Who We Are
    • Press Releases
    • SANE Vax in the News
    • Contact Us

SaneVax, Inc.

The First International HPV Vaccine Information Clearinghouse

  • NEWS
    • Government Agencies
      • African
      • Asian
      • Australasian
      • European
      • North American
      • South American
      • United Nations
      • WHO
    • Pharmaceutical Companies
      • CSL Biotherapies
      • GlaxoSmithKline
      • Inovio Pharmaceuticals
      • Liquidia Technologies
      • Merck & Co.
      • Novartis
      • Pfizer
      • Qiagen
      • Sanofi Aventis
      • Sanofi Pasteur MSD spmsd
      • Wyeth Laboratories
    • Science & Medicine
      • Cancer
      • Clinical Trials
      • Environmental Health
      • Heavy Metal Toxicity
      • HPV Science
      • Influenza
      • Meningitis
      • Pertussis
      • Pharmaceuticals
      • Rotavirus
      • STD’s
      • Vaccine Science
      • Women’s Health
    • Vaccine Adverse Events
    • Vaccine Injury Reporting
      • VAERS
      • VAMPSS
    • Vaccine Litigation
    • Vaccine Marketing
    • Vaccine Politics/People
    • Vaccine Victims
      • Cervarix Injuries
      • DTP/DTaP Injuries
      • Fluvax Injuries
      • Fluzone Injuries
      • Gardasil / Silgard Injuries
      • Menomune Injuries
      • MMR Injuries
      • Polio Vaccine Injuries
      • Synflorix Injuries
      • Yellow Fever Vaccine
    • Vaccines
      • Anthrax
      • Breast Cancer
      • Chicken Pox
      • Cholera
      • Combination Vaccines
      • Diphtheria
      • Hepatitis B
      • HPV
      • Influenza Vaccines
      • Malaria
      • Measles
      • Meningitis Vaccines
      • MRSA
      • Mumps
      • Norovirus
      • Pertussis Vaccines
      • Pneumococcal Disease
      • Polio
      • Rotavirus Vaccines
      • Shingles
      • Smallpox
      • TB
      • Tetanus
      • Typhoid
      • Yellow Fever Vaccine
    • Vaccines and the Media
  • WORLD NEWS
    • Africa
    • Asia
    • Australasia
    • Europe
    • North America
    • South America
  • RESEARCH
    • Cancer Research
    • Cervarix Vaccine
    • Gardasil/Silgard Vaccine
    • Human Pap. Research
    • Immunization Practices
    • Neurology
    • Vaccine Adjuvants
    • Vac. Ingredient Research
    • Vaccine Injuries
    • Vaccine Preservatives
    • Vaccine Related Research
    • Vaccine Safety
  • CITIZENS SPEAK
    • Cervical Cancer Debate
    • HPV Vax
      • Australian Concerns
      • Canadian Concerns
      • Irish Concerns
      • Spain Concerns
      • UK Concerns
      • United States Concerns
You are here: Home / NEWS . . . . . . . . / Vaccines / Anthrax / Proposed Government Experiment to Test Anthrax Vaccine on Children

Proposed Government Experiment to Test Anthrax Vaccine on Children

March 1, 2013 By Norma 1 Comment

Presentation to the Presidential Commission for the Study of Bioethical Issues, Amy Gutmann, PhD, Chair

Re: Ethical Issues Associated with Countermeasures for Children

By the Alliance for Human Research Protection

Proposed Anthrax Trials in Children?
Proposed Anthrax Trials in Children?

This Presidential Commission spent 4 meetings and the greater part of a year deliberating about the ethics of testing the anthrax vaccine on children, but somehow ignored the most basic information about the vaccine: its effectiveness after exposure to inhalation anthrax is unknown, and the lack of a reliable animal model makes any calculation of effectiveness and dosing impossible. What is known is that BioThrax is a dangerous vaccine. The FDA-approved 2002 label1 states: 5% to 35% of adults who were vaccinated suffered adverse events. Those adverse events encompass local adverse reactions—such as, bruising, inflammation, swelling, pain, and fever; systemic reactions—such as, muscle aches, joint aches, headaches, malaise, rashes, chills, fever, nausea. The FDA-approved 2012 label2 states:

“acute allergic reactions, including anaphylaxis…Stevens Johnson syndrome have occurred with BioThrax… [and] BioThrax can cause fetal harm when administered to a pregnant woman. If this drug is used during pregnancy, or if the patient becomes pregnant while ta king this drug, the patient should be apprised of the potential hazard to a fetus.”

A “pivotal safety / immunogenicity trial” conducted by the Centers for Disease Control reported in the Journal of the American Medical Association (JAMA, 2008)3 that 12% of the adult subjects suffered “serious adverse events” (SAE) during the 43 month trial. SAEs are defined as

“death, life-threatening events, initial inpatient hospitalization or prolongation of hospitalization, significant or persistent disability or incapacity…”

The following presentation is made on behalf of The Alliance for Human Research Protection (AHRP),  a national 501-C3 human rights organization dedicated to advancing responsible and ethical medical  research practices. We will make the case that the proposed pediatric anthrax vaccine trial and broader non-specific “countermeasures research” in children, involving greater than minimal risk is unethical and unapprovable in the absence of a clear and present danger to children.

At the close of the Commission’s May 17, 2012 meeting, you pinpointed4 precisely the two most important factors for the Commission to consider when developing its recommendations. First, it needed to consider the relevant scientific facts and the state of knowledge relating to the issues involved in pediatric “countermeasures research”:

“To say that research on one vaccine should go forward really requires having facts, not just the framework…. I would definitely agree you can’t come to a decision in this matter without having the facts… I would request that all of you who work in the domain of the facts get us the relevant facts — all of the relevant facts that are known or any that are unknown– that would need to be gotten… that would have to be known before a final decision should be made on specifically a vaccine, an Anthrax vaccine for children… it’s really important for us to know what is the state of knowledge of the facts in this matter…”

You also pinpointed the most important ethical consideration which is tacitly overlooked by many IRBs: whose children would be the subjects of countermeasures research?

“…if the people who are in favor of this would feel that it was the right thing to do to volunteer their children, that would send a very strong signal about the confidence in the rightness of doing this.”

Unfortunately none of the invited presenters at the Commission’s subsequent public meetings provided “the facts.”  No one even referred to the disclosures contained in the FDA-approved vaccine label which explicitly states: “The safety and efficacy of BioThrax in a post-exposure setting have not been established.”5 And no one ever mentioned volunteering their own children for such a study.

Read the entire presentation here.

Related

Filed Under: Anthrax, HHS, United States, Vaccine Science Tagged With: anthrax vaccine, proposed pediatric trials

Comments

  1. Ana Aitawa says

    May 10, 2018 at 6:59 am

    The global injection drug delivery devices market to attain US$ 8 Billion by 2023, growing at a CAGR of 5.6% over the forecast period.
    Visit the global injection drug delivery devices market by product type [syringe/needles products (standard syringes/needles, safety syringes/needles); and vascular access devices (short peripheral catheters, midline catheters, peripherally inserted central catheters, central venous catheters, implantable ports)]; by geography and forecast 2015-2023 at https://www.ihealthcareanalyst.com/report/injection-drug-delivery-devices-market/

    Reply

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Follow Us

SaneVax on FacebookSaneVax on TwitterSaneVax on LinkedInSaneVax on YoutubeSaneVax RSS Feed

Help Support SaneVax

Notice: We need your support. This massive research & presentation comes from a team of volunteers. We need your help to keep this critical information available.



SaneVax relies on support from participants like you. We are a 501 (c)(3) non-profit corporation, donations are tax deductible. Help keep this venue available and support the spirit – Thank you!

This Week’s Survivor

Gardasil: We're all in this together

Gardasil: My Family Suffers with Me

Categories

Links

  • Creating an HPV Industry
  • File a VAERS Report
  • Gardasil and Unexplained Deaths
  • HPV Industry Timeline
  • HPV Mechanisms of Action in Women
  • HPV Vaccine Fact Sheet
  • Petition: Rescind HPV Vaccine Approval
  • Presentation to the FDA
  • Supreme Court Arguments

HPV Vaccine VAERS Reports

Description 12/14/2019  TOTAL
Disabled 3,092
Deaths 523
Did Not Recover 13,072
Abnormal Smear 695
Cervical Cancer 186
Infertility 52
Life-threatening 1,001
Emergency Room 15,419
Hospitalized 6,448
Extended Hosp. Stay 304
Serious 9,497
Total Adverse Events 64,270

Access expanded report here.

Related

Subscribe2


 

Log In

Featured Video

gardasil vaccines sudden death

Gardasil Vaccines Sudden Death. Must see this video

News

SaneVax News Blog!
News

Videos

Safety • Victims • Pharma
No Genetic Epidemic

Contact

Contact S.A.N.E.Vax
S.A.N.E.VAX log thumbnail

Copyright © 2023 SaneVax, Inc. · Site by TheWebElves.com a div. of KalaRhythms.org · Log in

 

Loading Comments...